Table 3.

Global Advisory Committee for Vaccine Safety (GACVS) reports released during 1999–2019 that included review of data on autism

GACVS report		Exposure	Outcome	Report link
2002	June	DTP	Neurodevelopmental delay	https://www.who.int/vaccine_safety/committee/reports/wer7747.pdf?ua=1
2002	December	Multiple	Autism	https://www.who.int/vaccine_safety/committee/reports/wer7804.pdf?ua=1
2004	December	Multiple	Autism, neurodevelopmental delay	https://www.who.int/vaccine_safety/committee/topics/thiomersal/wer8001.pdf?ua=1
2012	June	Aluminium	Autism	https://www.who.int/vaccine_safety/committee/topics/thiomersal/wer8730.pdf?ua=1
2012	June	Thiomersal	Mercury levels, autism, neurodevelopmental delay, special high-risk groups (eg, premature infants, immunocompromised infants)	https://www.who.int/vaccine_safety/committee/topics/thiomersal/wer8730.pdf?ua=1

DTP, diphtheria, tetanus and pertussis vaccine.